Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjing Xiang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
ACS Biomaterials Science & Engineering|May 30, 2024
Photoresponsive Hydrogels for Tissue EngineeringRui Luo, Xianjing Xiang, Qiangqiang Jiao, et al.
Molecular Pharmaceutics|March 7, 2025
Suppression of Liver Fibrogenesis with Photothermal Sorafenib Nanovesicles via Selectively Inhibiting Glycolysis and Amplification of Active HSCsXianjing Xiang, Yaru Shao, Li Xiang, et al.
International Journal of Pharmaceutics|February 27, 2025
Inhibition of HSC proliferation and hepatic fibrogenesis with Erythrocyte membrane coated Doxorubicin/Black phosphorus nanosheetsLi Xiang, Xianjing Xiang, Qiangqiang Jiao, et al.
ACS Applied Materials & Interfaces|June 22, 2026
FAP-α-Responsive Size-Transformable Lipid Nanoparticles for Stromal Remodeling and Enhanced Drug Penetration in Fibrotic Hepatocellular CarcinomaLi Xiang, Jiachi Xu, Yukang Lin, et al.
International Journal of Pharmaceutics|December 9, 2024
Targeting hyperactive mitochondria in activated HSCs and inhibition of liver fibrogenesis in mice using sorafenib complex micellesLi Xiang, Yuting Qin, Lei Li, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
ACS Biomaterials Science & Engineering|May 30, 2024
Photoresponsive Hydrogels for Tissue EngineeringRui Luo, Xianjing Xiang, Qiangqiang Jiao, et al.
Molecular Pharmaceutics|March 7, 2025
Suppression of Liver Fibrogenesis with Photothermal Sorafenib Nanovesicles via Selectively Inhibiting Glycolysis and Amplification of Active HSCsXianjing Xiang, Yaru Shao, Li Xiang, et al.
International Journal of Pharmaceutics|February 27, 2025
Inhibition of HSC proliferation and hepatic fibrogenesis with Erythrocyte membrane coated Doxorubicin/Black phosphorus nanosheetsLi Xiang, Xianjing Xiang, Qiangqiang Jiao, et al.
ACS Applied Materials & Interfaces|June 22, 2026
FAP-α-Responsive Size-Transformable Lipid Nanoparticles for Stromal Remodeling and Enhanced Drug Penetration in Fibrotic Hepatocellular CarcinomaLi Xiang, Jiachi Xu, Yukang Lin, et al.
International Journal of Pharmaceutics|December 9, 2024
Targeting hyperactive mitochondria in activated HSCs and inhibition of liver fibrogenesis in mice using sorafenib complex micellesLi Xiang, Yuting Qin, Lei Li, et al.
Pageof 1